Novo Nordisk lowers Ozempic cost to $499 per month for uninsured U.S. patients, expanding access through NovoCare and 70,000 ...

Novo Nordisk and GoodRx announced a partnership this week to sell products Ozempic and Wegovy at half their normal cost to patients who pay for the medications with cash. Starting this week, ...

What To Know: Under the agreement, all strengths of the medications will now be available to eligible self-paying patients at $499 per month through GoodRx's platform.

Last year, GLP-1s dominated many employer conversations as demand surged and pressure mounted from employees clamoring for ...

GoodRx reports that insurance formularies are shrinking, leading to fewer covered medications and increased restrictions on ...

Novo said cash-paying Americans can now buy Ozempic for $499 per month through various channels including its official ...

After Novo Nordisk revealed Ozempic will retail for half-price at 70,000 pharmacies throughout the US, people are questioning ...

SoFi reports that their survey found most personal loan borrowers take less than $10,000, often for debt consolidation and ...

Novo Nordisk is slashing the price of its blockbuster diabetes drug Ozempic for U.S. patients who self-pay or are uninsured.

A rise in shipments of smartphones, especially in Southeast Asia, helped to boost Xiaomi's second-quarter revenue by 30.5%, ...

Novo Nordisk (NYSE: NVO) stock is up 2.2% through 10:30 a.m. ET on Viking's bad news. Where to invest $1,000 right now? Our ...

Glucagon-like peptide 1 receptor agonist injectable use was 26.5% in 2024 nationally among adults diagnosed with diabetes.